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Abstract 
Frequent preventable emergency department (ED) visits is an area of great concern among healthcare administrators. Although 
pharmacist interventions have been shown to reduce re-hospitalizations, studies demonstrating reduction in ED utilizations among the 
elderly are limited. Additionally, factors influencing readmissions in the ED are multifactorial. Hence, some healthcare systems struggle 
to reduce readmissions using pharmacy services. This has been a major issue facing care provided to the elderly in the ED. As healthcare 
care systems develops and implement a collaborative pharmacist and physician/mid-level provider comprehensive transitional model 
of care in the ED, the quality of care provided to the elderly will be enhanced which will ultimately translate to reduced inappropriate 
ED visit and re-hospitalization with corresponding reduction in financial burden placed on both the patient, caregiver and the society. 
Therefore, the objective of this article is to discuss our process with implementing pharmacist-providers transitional model in the ED. 
The intent is to elucidate some pharmacist-intervention principles and a pharmacist-driven, patient-care transitional model that would 
provide direction for other healthcare systems to improve ED visits within their locality. 
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Introduction 
Preventable emergency department (ED) visits associated with 
chronic illness among the geriatric population (65 yrs +) are 
growing in number. In California, it was observed that ED visit 
rates were highest for renal disease (49%), diseases of the 
blood and blood-forming organs (43.8%), abdominal pain 
(30%), other undefined symptoms (27%), and hypertension 
(27%). 1 With 15% of all ED visits being made by patients at least 
65 years and with the growing population of elderly population 
which is projected to increase from 14%, in 2012, to 20% in 
2030;2 the incidence of ED visits associated with chronic disease 
across the states of the United States will continue to rise. The 
rising number of preventable ED visits among the elderly will 
not only financially impact the healthcare system but may 
adversely affect the individual patients. For example, in a 
matched cohort study, Nagurney et al observed an increased 
risk of functional decline by 17% among patients who visited 
the ED when compared to patients who did not.3 Although the 
result of the aforementioned observation is merely an 
association, it underscores the patient-related adverse 
outcomes associated with frequent ED visits among geriatric 
patients.  It is noteworthy that among the elderly, medication-
related problems are one of the significant reasons for 
increased ED utilizations. Therefore, it is reasonable to 
hypothesize that pharmacist intervention would improve ED  
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utilizations. Although Pharmacist interventions have been 
shown to improve medication discrepancy,4 limited, 
randomized studies have demonstrated the impact of 
pharmacist interventions with the reduction of preventable ED 
use. Consequently, some healthcare systems struggle to reduce 
readmissions using pharmacy services. Hence, the objective of 
this article is to discuss our process with implementing 
pharmacist-providers transitional model in the ED with the 
intent of elucidating pharmacist intervention principles and a 
pharmacist-driven, patient-care transitional model that would 
provide direction for other healthcare systems to improve ED 
visits among the elderly within their locality. 
Our Experience with Implementation of Transitional Model of 
Care 
In 2009, we conducted a pilot study to evaluate the 
effectiveness of a pharmacist-led implementation of 
medication reconciliation services and medication therapy 
management, with student pharmacist assistance. 5 The results 
of the study revealed a reduction in the frequency of combined 
ED visit and re-hospitalization among  ED patients seen by 
student  pharmacists under the direction of a pharmacist when 
compared to  ED patients who followed the usual care (mean 
difference in number of visits: 25%, P = 0.047).5 Although this 
pilot study was not a randomized clinical trial, the results of the 
pilot study was consistent with a randomized study published 
by Gillespie et al in Sweden.6  In Gillespie et al study, they 
observed a 16% reduction of combined ED visits and hospital 
readmissions among patients seen by pharmacists when 
compared to patients who did not (estimate 0.84%; 95% 
confidence interval [CI], 0.72 – 0.99).6 
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Following the results of our pilot study, we conducted a 
randomized control study in order to further evaluate the 
impact of pharmacist provisions of medication reconciliation 
and medication-therapy management on primary care visits, ED 
visits and urgent care visits. 7 In this study, we observed an 
increased number of primary care visits (odds ratio [OR] 1.5; 
95% [CI] 1.04 – 2.1) and a reduction in the number of urgent 
care visits (OR 0.5; 95% CI 0.3 – 0.9) among patients taking at 
least one chronic medication who were seen by a pharmacist 
compared to those who did not.7   However, no difference was 
observed in the frequency of ED visits between the two groups. 
We believed that the lack of statistical significant differences 
observed in the number of ED visits between the two groups 
was related to other quality improvement projects 
implemented by the health systems due to the roll out of the 
Affordable Care Act. Nonetheless, we concluded that the 
increase in the number of primary care visits and the reduction 
of urgent care visits was a positive sign of transitioning patients 
towards appropriate use of primary care services, which may 
advertently lead to an improvement in ED utilizations. 7   
 
Based on our positive experiences, we proposed that for the 
healthcare system to effectively improve preventable ED visits 
among elderly patients, ED pharmacist care model should 
integrate 4 fundamental intervention principles. These four 
fundamental intervention principles are as follows: 1.) Enhance 
the medication reconciliation process, 2.) Deprescribe (with 
respect to polypharmacy) 3.) Improve medication adherence, 
4.) Improve patient medication education and counseling. The 
integration of the proposed intervention principles is based on 
the hypothesis that they are not independent of each other, 
and any deficiency in one of the intervention principles may 
lead to inappropriate ED utilization and adverse outcomes 
among the elderly. 8-11 For example, though pharmacist 
provision of medication reconciliation alone has been shown to 
improve medication discrepancy, its sole application has not 
been shown to improve inappropriate ED utilizations. This is 
consistent with other principles when independently applied. 
Thus, highlighting the need to integrate the aforementioned 
four intervention principles in a pharmacist-care transitional 
model. 
Description of the Process Model 
Our patient care model (see Figure 1) systematically followed a 
stepwise approach and integrated into our ED triage process. It 
is noteworthy that some activities in the model, as will be 
described, either occurred simultaneously or concurrently. A 
description of the process is as follows: 
Step 1. Patient’s Profile Review: Upon presentation in the ED, 
Triage nurse alerts pharmacist for medication review. Five 
activities will occur concurrently at three different process 
levels as follows:  
• Level 1: Pharmacist review of three important key 
elements: first, a review of past medical history; second, a 
history of current diseases and laboratory values (if 
available); third, review of past medication history (PMH) if 
available. The rationale for this interview or profile review 
is to correlate or identify any medication-related problem 
associated with history of present illness.  
• Level 2: A trained Pharmacy technician or a student 
pharmacist will collect medication history.  
• Level 3:  ED Patient will be given a survey which has been 
psychometrically validated to proactively evaluate 
patient’s medication-taking self-efficacy. This validated 
tool is known as the Okere-Renier Survey.12 The Okere-
Renier survey will be used by the pharmacist to proactively 
identify any deficiency in attitude or perception that may 
potentially lead to medication non-adherence. This survey 
can either be completed by the patient or the caregiver. 
Step 2.  Verification of patient’s medication history: the 
patient’s medication history will be compared with the 
medication history obtained from a single community 
pharmacy or a multiple community pharmacy (if the patient has 
more than one pharmacy). When the latter activity occurs, the 
ED provider will enter the patient’s room to conduct a medical 
screening exam. 
Step 3. Medication Therapy Management: The ED 
Physician/Provider and Pharmacist will quickly analyze 
information obtained. Critical information to be discussed are 
as follows: medication discrepancies, adherence patterns, 
drug-drug interactions, drug-disease interactions, potential 
drug-related adverse outcomes/side-effects, possible 
labs/imaging that could be obtained to support decisions and 
opportunities to improve care. Finally, a potential medication 
optimization related to the patient’s comorbidities and 
deprescribing will be discussed.  
Stage 4:  Patient education/counseling: following step three, a 
pharmacist will provide medication information to the patient 
and a complete list of their accurate medication list. This will 
also be documented in the electronic health record (EHR). 
Information obtained from the Okere-Renier survey will be 
reviewed by the Pharmacist and will guide the pharmacist’s 
approach in helping the patient improve his or her medication-
taking self-efficacy. 
Stage 5: Discharge letter provided: in addition to a discharge 
letter being provided to the patient’s primary care provider by 
the nurse, the pharmacist provides a short letter (usually less 
than a page) to summarize the patient’s history of current 
illness, and to detail observed medication-related problems, 
the suggested approach to management and continued care 
after discharge. This is communicated to the primary care 
provider through electronic communication and included in the 
discharge letter sent by the provider. Finally, a copy of the letter 
written by the pharmacist is provided to the patient to aid with 
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patient discussion with his or her primary provider. Most 
importantly, the content of this letter is also discussed with the 
patient prior to discharge. This latter activity is based on two 
rationales; first, the transfer of discharge letters (provided by 
ED providers) to the patient’s outpatient provider is either not 
timely or lacks important information that would guide 
appropriate management and subsequently prevent 
readmissions. 13, 14 Secondly, discussing and providing the letter 
to the patients will empower them to discuss their care with 
their provider. 
Discussion 
Over the years, the primary objective of ED has evolved beyond 
treating critically ill patients to managing patients who have 
chronic diseases. With the elderly population being expected to 
increase exponentially in coming decades, the dire need to 
ameliorate inappropriate ED visit among the elderly population 
is widely acknowledged among healthcare organizations and 
policy makers.  
As previously stated, many of the elderly that frequently visit 
the ED carry a high burden of chronic diseases, have multiple 
comorbidities and polypharmacy issues.15 The proposed 
transitional model of care process is based on a premise that 
the integration of pharmacists in the ED, as a frontline clinician, 
leads to an improved comprehensive medication review and 
minimize medication discrepancies prior to ED discharge. This 
will ultimately improve the transition of care and lead to better 
health outcomes.  Thus, the adoption of this model will enhance 
healthcare system’s ability to creatively use a interprofessional 
approach in the care of the elderly in the ED. 
A unique characteristic of this model of care process is the 
ability to integrate several intervention principles such as 
medication reconciliation process, medication review that 
would lead to de-prescribing and optimization of medication 
therapy, helping patients improve medication adherence, 
provision of patient medication education and discharge 
counseling. As evident in our studies, 5,7 it creates opportunities 
for the ED pharmacist to enhance patients’ self-efficacy during 
ED visit which will ultimately lead to better health outcomes. 
Additionally, the proposed transition of model of care can 
enhance the algorithm to improve the safety and effectiveness 
of transition of care, as developed by Kessler et al.16 The 
aforementioned algorithm discussed the 5 step approach to 
transition of care in the ED, which involves minimizing 
interruptions, interprofessional approach, identification of high 
risk patients, identify the receiving patient and “closing the 
loop” which allowed time to address any questions.16 Thus, this 
model can easily be integrated in the algorithm to provide a 
true interprofessional approach to care. 
Design and implementation of this proposed model is not 
without challenges. One of the noteworthy challenges was 
identifying the most productive time to have a pharmacist 
present in the ED as the institution, prior to implementation of 
the model, did not have a 24-hour ED pharmacy service. A 
collaboration and discussion between the ED team and the 
pharmacy team went a long way, not only to identify the right 
time period for maximal patient outreach but to overcome 
other challenges that the healthcare systems may encounter. 
Additionally, allocation of resources and staffing adjustment 
were potential barriers.  The creative integration of either 
pharmacy students or trained pharmacy technician and/or 
post-graduate pharmacy resident in the model is key to 
overcoming the issue of resource allocation and staffing 
adjustment.   
Despite these challenges, one unique advantage of this model 
is its simplicity to implement or to adapt irrespective of the type 
of healthcare system such as rural or urban, academic or non-
academic healthcare system. However, more pragmatic clinical 
studies will be needed to further evaluate the effectiveness of 
the proposed pharmacist transition of care model in improving 
health outcome, quality of care measures and its ease of 
implementation. 
Conclusion 
As previously stated, some healthcare systems struggle to 
reduce readmission-using pharmacy services. Nonetheless, 
reducing preventable readmissions is feasible when 
pharmacists and providers (including mid-level providers) 
collaboratively provide direct patient care adeptly. Efficient 
provisions of direct patient care in the emergency department 
will be dependent on the patient-care process model 
established. We propose that any patient-care model 
established should foster integration of interdisciplinary team 
members and the four fundamental intervention principles. 
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Figure 1 
 
 
 
 
 
 
Patient arrives 
at the 
emergency 
department 
(ED) 
 Step 1  
Act 1: Pharmacist reviews 
profile 
Act 2: Technician or 
student -pharmacist 
interviews 
patient/caregiver for 
medication history 
Act 3: Survey patient for 
level of medication taking 
self-efficacy.  This is 
conducted by a technician 
or student -pharmacist 
 
Step 2 
Act 1: Verification of patient’s 
medication history 
(performed outside patient’s 
room) 
Act 2: Medical screening exam 
by ED provider (conducted in 
patient’s room) 
 Step 3: Medication 
Therapy Management 
(conducted outside 
patient’s room) – Patient 
care discussion between 
ED provider and 
 
Triage nurse alerts ED 
pharmacist (if patient 
has at least one 
chronic medication) 
 Step 4:  Patient 
Education/Counseling – 
performed by either 
pharmacist or student 
pharmacist 
Step 5: Discharge letter 
discussed with patient – 
performed by 
pharmacist 
Figure 1: Schematic 
Representation of Pharmacist-
Driven ED Care Model 
 
Act: Activity (denotes type of 
activity that occurred 
concurrently with other activities) 
 
Technician: Denotes a trained 
pharmacy technician 
